Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Change in Acquisitions & Divestments (2018 - 2024)

Historic Change in Acquisitions & Divestments for Verastem (VSTM) over the last 7 years, with Q2 2024 value amounting to $29.0 million.

  • Verastem's Change in Acquisitions & Divestments changed N/A to $29.0 million in Q2 2024 from the same period last year, while for Dec 2024 it was $60.0 million, marking a year-over-year change of. This contributed to the annual value of $60.0 million for FY2024, which is 1538.46% up from last year.
  • Latest data reveals that Verastem reported Change in Acquisitions & Divestments of $29.0 million as of Q2 2024.
  • Over the past 5 years, Verastem's Change in Acquisitions & Divestments peaked at $38.1 million during Q2 2021, and registered a low of $5.4 million during Q1 2021.
  • In the last 5 years, Verastem's Change in Acquisitions & Divestments had a median value of $26.6 million in 2022 and averaged $23.0 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first crashed by 8322.93% in 2021, then soared by 35116.28% in 2022.
  • Verastem's Change in Acquisitions & Divestments (Quarter) stood at $32.0 million in 2020, then rose by 3.74% to $33.2 million in 2021, then plummeted by 53.38% to $15.5 million in 2022, then fell by 16.13% to $13.0 million in 2023, then soared by 123.08% to $29.0 million in 2024.
  • Its Change in Acquisitions & Divestments stands at $29.0 million for Q2 2024, versus $31.0 million for Q1 2024 and $13.0 million for Q1 2023.